Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets

Methods in Enzymology

Volumn 401, Issue , 2005, Pages 287-307

  Townsend, Danyelle M ^a   Findlay, Victoria L ^a   Tew, Kenneth D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANFOSFAMIDE; DOCETAXEL; ENZYME INHIBITOR; GLUTATHIONE DISULFIDE; GLUTATHIONE TRANSFERASE; LEAD; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; NOV 002; O 2[2,4 DINITRO 5 (N METHYL N 4 CARBOXYPHENYLAMINO)PHENYL] 1 N,N DIMETHYLAMINO)DIAZEN 1 IUM 1,2 DIOLATE; PHOSPHOTRANSFERASE; PRODRUG; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; THIOREDOXIN; TLK 117; TLK 199; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; CLINICAL TRIAL; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; LIGAND BINDING; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL;

EID: 30144441610     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)01019-0     Document Type: Review

References (55)

1. Adachi T., Pimentel D.R., Heibeck T., Hou X., Lee Y.J., Jiang B., Ido Y., and Cohen R.A. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells J. Biol. Chem. 279 2004 29857 29862
2. Adler V., Yin Z., Fuchs S.Y., Benezra M., Rosario L., Tew K.D., Pincus M.R., Sardana M., Henderson C.J., Wolf C.R., Davis R.J., and Ronai Z. Regulation of JNK signaling by GSTp EMBO J. 18 1999 1321 1334
3. Adler V., Yin Z., Tew K.D., and Ronai Z. Role of redox potential and reactive oxygen species in stress signaling Oncogene 18 1999 6104 6111
4. Bailey H.H., Ripple G., Tutsch K.D., Arzoomanian R.Z., Alberti D., Feierabend C., Mahvi D., Schink J., Pomplun M., Mulcahy R.T., and Wilding G. Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan J. Natl. Cancer Inst. 89 1997 1789 1796
5. Callander N., Ochoa-Bayona J., Piro L., Guba S., Shapiro G., Williams S., Oliff I., Burris H., Jameson A., Patel K., Brown G., FAderl S., Estrov Z., and Emanuel P. Hematologic improvement following treatment with TLK199 (Telintra™), a novel glutathione analog inhibitor of GST P1-1, in myelodysplastic syndrome (MDS): Interim results of a dose-ranging phase 2a study Session Type: Poster Session 582-I. American Society Hematology 2004 Abstract no. 1428
6. Ciaccio P.J., Shen H., Kruh G.D., and Tew K.D. Effects of chronic ethacrynic acid exposure on glutathione conjugation and MRP expression in human colon tumor cells Biochem. Biophys. Res. Commun. 222 1996 111 115
7. Ciaccio P.J., Tew K.D., and LaCreta F.P. Enzymatic conjugation of chlorambucil with glutathione by human glutathione S-transferases and inhibition by ethacrynic acid Biochem. Pharmacol. 42 1991 1504 1507
8. Comporti M. Three models of free radical-induced cell injury Chem. Biol. Interact. 72 1989 1 56
9. Cross J.V., and Templeton D.J. Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain Biochem. J. 381 2004 675 683
10. Davis W. Jr., Ronai Z., and Tew K.D. Cellular thiols and reactive oxygen species in drug-induced apoptosis J. Pharmacol. Exp. Ther. 296 2001 1 6
11. Dong C., Yang D.D., Wysk M., Whitmarsh A.J., Davis R.J., and Flavell R.A. Defective T cell differentiation in the absence of Jnk1 Science 282 1998 2092 2095
12. Findlay V.J., Townsend D.M., Saavedra J.E., Buzard G.S., Citro M.L., Keefer L.K., Ji X., and Tew K.D. Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug Mol. Pharmacol. 65 2004 1070 1079
13. Gate L., Majumdar R.S., Lunk A., and Tew K.D. Increased myeloproliferation in glutathione S-transferase pi-deficient mice is associated with a deregulation of JNK and Janus kinase/STAT pathways J. Biol. Chem. 279 2004 8608 8616
14. Golemis E.A., Tew K.D., and Dadke D. Protein interaction-targeted drug discovery: Evaluating critical issues Biotechniques 32 2002 636 638 640, 642 passim.
15. Gotoh Y., and Cooper J.A. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction J. Biol. Chem. 273 1998 17477 17482
16. Hayes J.D., and Pulford D.J. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance Crit. Rev. Biochem. Mol. Biol. 30 1995 445 600
17. Henderson C.J., Smith A.G., Ure J., Brown K., Bacon E.J., and Wolf C.R. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases Proc. Natl. Acad. Sci. USA 95 1998 5275 5280
18. Herzenberg L.A., De Rosa S.C., Dubs J.G., Roederer M., Anderson M.T., Ela S.W., and Deresinski S.C. Glutathione deficiency is associated with impaired survival in HIV disease Proc. Natl. Acad. Sci. USA 94 1997 1967 1972
19. Hochedlinger K., Wagner E.F., and Sabapathy K. Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis Oncogene 21 2002 2441 2445
20. Joshi M.S., Ponthier J.L., and Lancaster J.R. Jr. Cellular antioxidant and pro-oxidant actions of nitric oxide Free Radic. Biol. Med. 27 1999 1357 1366
21. Kallunki T., Deng T., Hibi M., and Karin M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions Cell 87 1996 929 939
22. Keefer L.K. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates Annu. Rev. Pharmacol. Toxicol. 43 2003 585 607
23. Keefer L.K. Nitric Oxide (NO)- and Nitroxyl (HNO)-Generating Diazeniumdiolates (NONOates): Emerging Commercial Opportunities Curr. Top. Med. Chem. 5 2005 625 636
24. Keppler D., Leier I., and Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2 Biol. Chem. 378 1997 787 791
25. Kuzmich S., Vanderveer L.A., and Tew K.D. Evidence for a glycoconjugate form of glutathione S-transferase pI Int. J. Pept. Protein Res. 37 1991 565 571
26. Litwack G., Ketterer B., and Arias I.M. Ligandin: A hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions Nature 234 1971 466 467
27. Lo H.W., Antoun G.R., and Ali-Osman F. The human glutathione S-transferase P1 protein is phosphorylated and its metabolic function enhanced by the Ser/Thr protein kinases, cAMP-dependent protein kinase and protein kinase C, in glioblastoma cells Cancer Res. 64 2004 9131 9138
28. Lyttle M.H., Satyam A., Hocker M.D., Bauer K.E., Caldwell C.G., Hui H.C., Morgan A.S., Mergia A., and Kauvar L.M. Glutathione-S-transferase activates novel alkylating agents J. Med. Chem. 37 1994 1501 1507
29. Makino Y., Yoshikawa N., Okamoto K., Hirota K., Yodoi J., Makino I., and Tanaka H. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function J. Biol. Chem. 274 1999 3182 3188
30. Manevich Y., Feinstein S.I., and Fisher A.B. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST Proc. Natl. Acad. Sci. USA 101 2004 3780 3785
31. Morgan A.S., Ciaccio P.J., Tew K.D., and Kauvar L.M. Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines Cancer Chemother. Pharmacol. 37 1996 363 370
32. Morgan A.S., Sanderson P.E., Borch R.F., Tew K.D., Niitsu Y., Takayama T., Von Hoff D.D., Izbicka E., Mangold G., Paul C., Broberg U., Mannervik B., Henner W.D., and Kauvar L.M. Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase Cancer Res. 58 1998 2568 2575
33. Napoli C., and Ignarro L.J. Nitric oxide-releasing drugs Annu. Rev. Pharmacol. Toxicol. 43 2003 97 123
34. O'Dwyer P.J., LaCreta F., Nash S., Tinsley P.W., Schilder R., Clapper M.L., Tew K.D., Panting L., Litwin S., Comis R.L., and Ozols R.F. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid Cancer Res. 51 1991 6059 6065
35. Peterson J.D., Herzenberg L.A., Vasquez K., and Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns Proc. Natl. Acad. Sci. USA 95 1998 3071 3076
36. Powis G., Kirkpatrick D.L., Angulo M., and Baker A. Thioredoxin redox control of cell growth and death and the effects of inhibitors Chem. Biol. Interact. 111-112 1998 23 34
37. Rosario L.A., O'Brien M.L., Henderson C.J., Wolf C.R., and Tew K.D. Cellular response to a glutathione S-transferase P1-1 activated prodrug Mol. Pharmacol. 58 2000 167 174
38. Ruscoe J.E., Rosario L.A., Wang T., Gate L., Arifoglu P., Wolf C.R., Henderson C.J., Ronai Z., and Tew K.D. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways J. Pharmacol. Exp. Ther. 298 2001 339 345
39. Saavedra J.E., Billiar T.R., Williams D.L., Kim Y.M., Watkins S.C., and Keefer L.K. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver J. Med. Chem. 40 1997 1947 1954
40. Saavedra J.E., Bohle D.S., Smith K.N., George C., Deschamps J.R., Parrish D., Ivanic J., Wang Y.N., Citro M.L., and Keefer L.K. Chemistry of the diazeniumdiolates. O- versus N-alkylation of the RNH[N(O)NO](-) ion J. Am. Chem. Soc. 126 2004 12880 12887
41. Saavedra J.E., Shami P.J., Wang L.Y., Davies K.M., Booth M.N., Citro M.L., and Keefer L.K. Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: In vitro antileukemic activity J. Med. Chem. 43 2000 261 269
42. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 EMBO J. 17 1998 2596 2606
43. Satyam A., Hocker M.D., Kane-Maguire K.A., Morgan A.S., Villar H.O., and Lyttle M.H. Design, synthesis, and evaluation of latent alkylating agents activated by glutathione S-transferase J. Med. Chem. 39 1996 1736 1747
44. Schwabe R.F., Bradham C.A., Uehara T., Hatano E., Bennett B.L., Schoonhoven R., and Brenner D.A. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration Hepatology 37 2003 824 832
45. Shami P.J., Saavedra J.E., Wang L.Y., Bonifant C.L., Diwan B.A., Singh S.V., Gu Y., Fox S.D., Buzard G.S., Citro M.L., Waterhouse D.J., Davies K.M., Ji X., and Keefer L.K. JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity Mol. Cancer Ther. 2 2003 409 417
46. Shaulian E., and Karin M. AP-1 in cell proliferation and survival Oncogene 20 2001 2390 2400
47. Shen H., Tsuchida S., Tamai K., and Sato K. Identification of cysteine residues involved in disulfide formation in the inactivation of glutathione transferase P-form by hydrogen peroxide Arch. Biochem. Biophys. 300 1993 137 141
48. Terada K., Kaziro Y., and Satoh T. Ras-dependent activation of c-Jun N-terminal kinase/stress-activated protein kinase in response to interleukin-3 stimulation in hematopoietic BaF3 cells J. Biol. Chem. 272 1997 4544 4548
49. Tew K.D. Glutathione-associated enzymes in anticancer drug resistance Cancer Res. 54 1994 4313 4520
50. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., Bar-Sagi D., Jones S.N., Flavell R.A., and Davis R.J. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway Science 288 2000 870 874
51. Townsend D., and Tew K. Cancer drugs, genetic variation and the glutathione-S-transferase gene family Am. J. Pharmacogenomics 3 2003 157 172
52. Umansky V., and Schirrmacher V. Nitric oxide-induced apoptosis in tumor cells Adv. Cancer Res. 82 2001 107 131
53. Wang T., Arifoglu P., Ronai Z., and Tew K.D. Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus J. Biol. Chem. 276 2001 20999 21003
54. Yang Y.M., Bost F., Charbono W., Dean N., McKay R., Rhim J.S., Depatie C., and Mercola D. C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma Clin. Cancer Res. 9 2003 391 401
55. 2-induced cell death via coordinated regulation of stress kinases Cancer Res. 60 2000 4053 4057